ARCHIVES

Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions

This article is from The Cancer Letter archive.

Vol. 09 No. 48 | December 16, 1983

Download PDF Visit The Full Archive

Related Articles

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

April 29, 2005

Funding Opportunities

November 15, 2002

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002